Page last updated: 2024-11-07

penicillamine and Bile Duct Cancer

penicillamine has been researched along with Bile Duct Cancer in 2 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Research Excerpts

ExcerptRelevanceReference
"Cholangiocarcinoma complicating primary sclerosing cholangitis often was detected at an advanced tumor stage, which precluded effective therapy, and overall median survival was 5 months."2.67Cholangiocarcinoma complicating primary sclerosing cholangitis. ( Coffey, RJ; LaRusso, NF; Nagorney, DM; Rosen, CB; Wiesner, RH, 1991)
"Primary sclerosing cholangitis is a generally progressive, sometimes fatal, chronic hepatobiliary disorder for which no effective medical or surgical therapy now exists."2.40The Fifth Carlos E. Rubio Memorial Lecture. Sclerosing cholangitis: pathogenesis, pathology, and practice. ( Larusso, NF, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Larusso, NF2
Rosen, CB1
Nagorney, DM1
Wiesner, RH1
Coffey, RJ1

Reviews

1 review available for penicillamine and Bile Duct Cancer

ArticleYear
The Fifth Carlos E. Rubio Memorial Lecture. Sclerosing cholangitis: pathogenesis, pathology, and practice.
    Puerto Rico health sciences journal, 1999, Volume: 18, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biopsy; Chelating Age

1999

Trials

1 trial available for penicillamine and Bile Duct Cancer

ArticleYear
Cholangiocarcinoma complicating primary sclerosing cholangitis.
    Annals of surgery, 1991, Volume: 213, Issue:1

    Topics: Adenoma, Bile Duct; Adult; Bile Duct Neoplasms; Cholangitis, Sclerosing; Combined Modality Therapy;

1991